Molecular Therapy: Oncolytics (Mar 2020)

Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis

  • Anahid Jewett,
  • Janko Kos,
  • Kawaljit Kaur,
  • Tahmineh Safaei,
  • Christine Sutanto,
  • Wuyang Chen,
  • Paul Wong,
  • Artin Keshishian Namagerdi,
  • Changge Fang,
  • Yuman Fong,
  • Meng-Wei Ko

Journal volume & issue
Vol. 16
pp. 41 – 52

Abstract

Read online

Natural killer (NK) cells are the key immune effectors with the ability to mediate selection and differentiation of a number of different cancer stem cells/undifferentiated tumors via lysis, and secreted or membrane-bound interferon (IFN)-γ and tumor necrosis factor (TNF)-α, respectively, leading to curtailment of tumor growth and metastasis. In this review, we present an overview of our recent findings on the biology and significance of NK cells in selection and differentiation of stem-like tumors using in vitro and in vivo studies conducted in humanized-BLT mice and in cancer patients. In addition, we present current advances in NK cell expansion and therapeutic delivery, and discuss the utility of allogeneic supercharged NK cells in the treatment of cancer patients. Moreover, we discuss the potential loss of NK cell numbers and function at the neoplastic and pre-neoplastic stages of tumorigenesis in induction and progression of pancreatic cancer. Therefore, because of their indispensable role in targeting cancer stem-like/undifferentiated tumors, NK cells should be placed high in the armamentarium of tumor immunotherapy. A combination of allogeneic supercharged NK cells with other immunotherapeutic strategies such as oncolytic viruses, antibody-dependent cellular cytotoxicity (ADCC)-inducing antibodies, checkpoint inhibitors, chimeric antigen receptor (CAR) T cells, CAR NK cells, and chemotherapeutic and radiotherapeutic strategies can be used for the ultimate goal of tumor eradication. Keywords: NK cells, cancer stem cells, CSCs, differentiation, cancer immunotherapy, osteoclasts, supercharged NK cells, humanized-BLT mice, pre-neoplastic, KRAS